» Articles » PMID: 36045149

Primary Aldosteronism - a Multidimensional Syndrome

Overview
Specialty Endocrinology
Date 2022 Aug 31
PMID 36045149
Authors
Affiliations
Soon will be listed here.
Abstract

Primary aldosteronism is a common cause of hypertension and is a risk factor for cardiovascular and renal morbidity and mortality, via mechanisms mediated by both hypertension and direct insults to target organs. Despite its high prevalence and associated complications, primary aldosteronism remains largely under-recognized, with less than 2% of people in at-risk populations ever tested. Fundamental progress made over the past decade has transformed our understanding of the pathogenesis of primary aldosteronism and of its clinical phenotypes. The dichotomous paradigm of primary aldosteronism diagnosis and subtyping is being redefined into a multidimensional spectrum of disease, which spans subclinical stages to florid primary aldosteronism, and from single-focal or multifocal to diffuse aldosterone-producing areas, which can affect one or both adrenal glands. This Review discusses how redefining the primary aldosteronism syndrome as a multidimensional spectrum will affect the approach to the diagnosis and subtyping of primary aldosteronism.

Citing Articles

Comparison of the clinical significance of lymphocyte-based inflammatory indices between the two major subtypes of primary aldosteronism.

Watanabe D, Morimoto S, Morishima N, Ichihara A Endocrine. 2025; .

PMID: 39954166 DOI: 10.1007/s12020-025-04193-z.


Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model.

You M, Lu Z, Wang B, Liu M, Zhou Q, Li L PLoS One. 2025; 20(2):e0314943.

PMID: 39946402 PMC: 11824956. DOI: 10.1371/journal.pone.0314943.


Oral Sodium Loading Test Is More Sensitive Than Seated Saline Infusion Test to Confirm Overt Primary Aldosteronism.

Duquet L, Lefebvre L, Lemaire-Paquette S, Malick M, Mallet P, St-Jean M J Endocr Soc. 2025; 9(3):bvae209.

PMID: 39911522 PMC: 11795192. DOI: 10.1210/jendso/bvae209.


The application value of ipsilateral superselective adrenal arteriography and adrenal venography in patients with primary aldosteronism undergoing adrenal artery embolization.

Liu S, Wang X, Wang P Hypertens Res. 2025; .

PMID: 39849050 DOI: 10.1038/s41440-025-02126-x.


Approach to Endocrine Hypertension: A Case-Based Discussion.

Borozan S, Kamrul-Hasan A, Shetty S, Pappachan J Curr Hypertens Rep. 2025; 27(1):8.

PMID: 39821533 PMC: 11739263. DOI: 10.1007/s11906-025-01323-w.


References
1.
CONN J . Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955; 45(1):3-17. View

2.
Wannachalee T, Lieberman L, Turcu A . High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It. Curr Hypertens Rep. 2022; 24(5):123-132. DOI: 10.1007/s11906-022-01176-7. View

3.
Zennaro M, Boulkroun S, Fernandes-Rosa F . Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020; 16(10):578-589. DOI: 10.1038/s41574-020-0382-4. View

4.
Fournier D, Luft F, Bader M, Ganten D, Andrade-Navarro M . Emergence and evolution of the renin-angiotensin-aldosterone system. J Mol Med (Berl). 2012; 90(5):495-508. PMC: 3354321. DOI: 10.1007/s00109-012-0894-z. View

5.
Vaidya A, Mulatero P, Baudrand R, Adler G . The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment. Endocr Rev. 2018; 39(6):1057-1088. PMC: 6260247. DOI: 10.1210/er.2018-00139. View